Elicera Therapeutics AB
F:8E8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Elicera Therapeutics AB
F:8E8
|
SE |
|
Indofood Sukses Makmur Tbk PT
IDX:INDF
|
ID |
|
P
|
Porn Prom Metal PCL
SET:PPM
|
TH |
|
E
|
Empire Diversified Energy Inc
OTC:MPIR
|
US |
|
T
|
Toyota Motor Corp
XMUN:TOM
|
JP |
Intrinsic Value
Is Elicera Therapeutics AB undervalued or overvalued?
See the intrinsic value estimate for 
Elicera Therapeutics AB and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Elicera Therapeutics AB looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with Elicera Therapeutics AB’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Elicera Therapeutics AB Does
Elicera Therapeutics AB is a Swedish biotech company that develops cancer treatments based on the body’s immune system. Its work centers on two main drug types: oncolytic virus therapies that are meant to attack tumors and help trigger an immune response, and CAR T-cell therapies that engineer immune cells to recognize cancer more effectively.
- Headquarters
- Sweden SE
- IPO date
- Jun 11, 2021
Earnings Waterfall
Elicera Therapeutics AB
The intrinsic value for Elicera Therapeutics AB (8E8) under the Base Case is hidden EUR.
Compared with the current market price of 0.2335 EUR, the stock appears hidden.